Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 6/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.36 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.36 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.36 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1812368 | 0.82 | MAPK1 (0.48) | ALDH1A1TDP1KMT2AKDM4EPOLB | |
| SCHEMBL347935 | 0.82 | TSHR (0.59) | ALDH1A1TDP1KMT2AKDM4EPOLB | |
| SCHEMBL1813258 | 0.80 | ALDH1A1 (0.47) | ALDH1A1TDP1KMT2AKDM4EPOLB | |
| SCHEMBL6455620 | 0.80 | SMN1; SMN2 (0.57) | ALDH1A1TDP1KMT2AKDM4EPOLB | |
| SCHEMBL28155919 | 0.78 | TSHR (0.47) | ALDH1A1TDP1POLBTSHRCES2 | |
| Hydrazine SCHEMBL8178152 | 0.78 | ALDH1A1 (0.36) | ALDH1A1TDP1KMT2AKDM4EPOLB | |
| SCHEMBL12383064 | 0.78 | ALDH1A1 (0.48) | ALDH1A1TDP1KMT2ATSHRCES2 | |
| SCHEMBL3329098 | 0.78 | GPR35 (0.48) | ALDH1A1TSHR | |
| SCHEMBL6963428 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TDP1KMT2AKDM4EPOLB | |
| SCHEMBL15262672 | 0.77 | ALDH1A1 (0.55) | ALDH1A1TDP1KMT2AKDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12240803-B2 | Diamine compound, and polyimide precursor and polyimide film using same | LG CHEM, LTD. (KR) | 2025-03-04 | — | — | US | disclosed |
| CN-113166046-B | Diamine compound, polyimide precursor using same, and polyimide film | 株式会社LG化学 | 2023-06-06 | — | — | CN | disclosed |
| US-20220017461-A1 | DIAMINE COMPOUND, AND POLYIMIDE PRECURSOR AND POLYIMIDE FILM USING SAME | LG CHEM, LTD. (KR) | 2022-01-20 | — | — | US | disclosed |
| CN-113166046-A | Diamine compound, and polyimide precursor and polyimide film using same | 株式会社LG化学 | 2021-07-23 | — | — | CN | disclosed |
| CN-102177135-A | Acylaminobenzamide derivatives | BAYER CROPSCIENCE AG | 2011-09-07 | — | — | CN | disclosed |
| US-20110201603-A1 | Novel Acylaminobenzamide Derivatives | BAYER CROPSCIENCE AG (DE) | 2011-08-18 | — | — | US | disclosed |
| EP-2318358-A2 | ACYLAMINOBENZAMIDE DERIVATIVES | Bayer CropScience AG (DE) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010015355-A2 | NOVEL ACYLAMINOBENZAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-02-11 | — | — | WO | disclosed |
| EP-0708077-B1 | Diamino compounds and methods for preparing them | CHISSO CORP (JP) | 2000-12-27 | — | — | EP | disclosed |
| US-5663440-A | Diamino compounds and methods for preparing them | CHISSO CORPORATION (JP) | 1997-09-02 | — | — | US | disclosed |
| EP-0708077-A1 | Diamino compounds and methods for preparing them | CHISSO CORPORATION (JP) | 1996-04-24 | — | — | EP | disclosed |
| EP-0211568-B1 | ANTICONVULSANT AGENTS | ELI LILLY AND COMPANY (US) | 1989-10-11 | — | — | EP | disclosed |
| US-4684748-A | BENZAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1987-08-04 | — | — | US | disclosed |
| EP-0211568-A1 | Anticonvulsant agents | ELI LILLY AND COMPANY (US) | 1987-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12240803-B2 | Diamine compound, and polyimide precursor and polyimide film using same | SRM, PCNA, PUF60 | ALDH1A1 1636/4885TDP1 1747/4885KMT2A 347/4885 |
| US-20220017461-A1 | DIAMINE COMPOUND, AND POLYIMIDE PRECURSOR AND POLYIMIDE FILM USING SAME | SRM, PCNA, PUF60 | ALDH1A1 1636/4885TDP1 1747/4885KMT2A 347/4885 |
| US-20110201603-A1 | Novel Acylaminobenzamide Derivatives | KCNB1, KCNA5, KCNA7 | ALDH1A1 271/4885TDP1 3523/4885KMT2A 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.